# A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM

> **NCT00980187** · PHASE4 · COMPLETED · sponsor: **LaborMed Pharma S.A.** · enrollment: 56 (actual)

## Conditions studied

- Hypertension
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Hydrochlorothiazide
- **DRUG:** Indapamide

## Key facts

- **NCT ID:** NCT00980187
- **Lead sponsor:** LaborMed Pharma S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2011-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980187, "A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00980187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*